[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
In the United States, [<sup>68</sup>Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first <sup>68</sup>Ga-radiopharmaceutical for imaging of somatostatin receptor (SSTR) positive gastroenteropancreatic neuroendocrine tumors while empl...
Saved in:
Main Authors: | Ute Hennrich (Author), Martina Benešová (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021) -
Automated GMP Production and Preclinical Evaluation of [<sup>68</sup>Ga]Ga-TEoS-DAZA and [<sup>68</sup>Ga]Ga-TMoS-DAZA
by: Julia Greiser, et al.
Published: (2022) -
Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023) -
Evaluation of [<sup>68</sup>Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections
by: Palesa C. Koatale, et al.
Published: (2024) -
Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
by: Zarif Ashhar, et al.
Published: (2022)